AdventHealth Orlando performs their first implant of Guardian™ System, revolutionizing cardiac care in Central FloridaEATONTOWN, N.J. and ORLANDO, Fla., June...
Myriad to support MD Anderson researchers studying metastatic renal cell carcinoma treatment selection and responseSALT LAKE CITY, June 12, 2023...
Company expands support for NASH disease education through patient advocacy partnerships and a new digital campaign for patients with at-risk...
Company plans to add multidrug-resistant Candida auris detection to its FDA-cleared T2Candida PanelLEXINGTON, Mass., June 05, 2023 (GLOBE NEWSWIRE) --...
MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on...
– Met Primary Endpoint with 63.4% Median Reduction in LDL-C (p<0.0001) – – 87.1% of Patients Treated with Combination of Obicetrapib and...
CALGARY, Alberta, June 02, 2023 (GLOBE NEWSWIRE) -- Providence Therapeutics Holdings Inc. ("Providence"), a biopharmaceutical company developing messenger RNA (mRNA)...
Masimo CO2, O3 and Sedline measurements are now available on Philips high acuity MX750 & MX850 IntelliVue monitors Philips patient...
Carlsbad, CA, June 01, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company advancing therapies...
D. Diaz CCPHP Dr. Diego Diaz Collaborates with Castle Connolly Private Health Partners to Create a Concierge Medical Program that...
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens...
With the Glitz and Glamour of a 20s Speakeasy, the Gala Honoured the Achievements of Dr. Kevin Schwartzman and the...
As of the data cutoff date, nine of the 14 evaluable patients treated with CUE-101+ KEYTRUDA® (pembrolizumab) demonstrated tumor regression,...
Company approaching Phase 2 topline data readout for prevention of post-surgical abdominal adhesions Continued momentum with execution of ongoing dose...
ST. LOUIS, May 23, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment...
Retrospective Clinical Data from Seven US Sites Published in Clinical Ophthalmology Sustained and clinically meaningful IOP reductions observed at 12...
Filed FDA submission for T2Biothreat Panel, implemented a restructuring program and announced exploration of strategic alternativesLEXINGTON, Mass., May 23, 2023...
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens...
The T2Biothreat Panel detects six biothreat pathogens and runs on the FDA-cleared T2Dx InstrumentLEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE)...
NewAmsterdam to review data on webcast conference call on June 5, 2023 at 8:00 a.m. ETNAARDEN, the Netherlands and MIAMI,...